Filing Details
- Accession Number:
- 0000902664-22-000093
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2022-01-06 19:43:55
- Reporting Period:
- 2022-01-04
- Accepted Time:
- 2022-01-06 19:43:55
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1799850 | Renovacor Inc. | RCOR | () | DE |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1493215 | Rtw Investments, Lp | 40 10Th Avenue 7Th Floor New York NY 10014 | No | No | Yes | No | |
1493219 | Rtw Master Fund, Ltd. | C/O Intertrust Corp. Serv. (Cayman) Ltd. One Nexus Way Camana Bay, Grand Cayman E9 KY1-9005 | No | No | Yes | No | |
1493280 | Roderick Wong | C/O Rtw Investments, Lp 40 10Th Avenue, 7Th Floor New York NY 10014 | No | No | Yes | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock, Par Value $0.0001 Per Share ("Common Stock") | Acquisiton | 2022-01-04 | 4 | $8.00 | 2,651,913 | No | 4 | P | Indirect | See footnote |
Common Stock | Acquisiton | 2022-01-05 | 100,195 | $8.00 | 2,752,108 | No | 4 | P | Indirect | See footnote |
Common Stock | Acquisiton | 2022-01-06 | 51,296 | $8.00 | 2,803,404 | No | 4 | P | Indirect | See footnote |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | P | Indirect | See footnote |
No | 4 | P | Indirect | See footnote |
No | 4 | P | Indirect | See footnote |
Footnotes
- The securities reported herein may be deemed beneficially owned by each of: (i) RTW Investments, LP (the "Adviser"), which is deemed the beneficial owner of shares of Common Stock held by RTW Master Fund, Ltd., RTW Innovation Master Fund, Ltd. and RTW Venture Fund Limited (collectively, the "Funds"), which are investment funds managed by the Adviser, and (ii) Roderick Wong, M.D., who serves as the Managing Partner and Chief Investment Officer of the Adviser. Dr. Wong exercises voting and dispositive control over the shares of Common Stock held by the Adviser and is therefore deemed to be a beneficial owner of securities owned or controlled by the Adviser.